[go: up one dir, main page]

NO870407L - Antihistaminpreparater inneholdende n-heterocyklyl-4-piperidinaminer. - Google Patents

Antihistaminpreparater inneholdende n-heterocyklyl-4-piperidinaminer.

Info

Publication number
NO870407L
NO870407L NO870407A NO870407A NO870407L NO 870407 L NO870407 L NO 870407L NO 870407 A NO870407 A NO 870407A NO 870407 A NO870407 A NO 870407A NO 870407 L NO870407 L NO 870407L
Authority
NO
Norway
Prior art keywords
alkyl
substd
alkoxy
furanyl
opt
Prior art date
Application number
NO870407A
Other languages
English (en)
Other versions
NO870407D0 (no
Inventor
Frans Eduard Janssens
Jozef Francis Hens
Joseph Leo Ghislanus Torremans
Jozef Jan Pieter Heykants
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO870407D0 publication Critical patent/NO870407D0/no
Publication of NO870407L publication Critical patent/NO870407L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO870407A 1986-02-03 1987-02-02 Antihistaminpreparater inneholdende n-heterocyklyl-4-piperidinaminer. NO870407L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82549186A 1986-02-03 1986-02-03

Publications (2)

Publication Number Publication Date
NO870407D0 NO870407D0 (no) 1987-02-02
NO870407L true NO870407L (no) 1987-08-04

Family

ID=25244134

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870407A NO870407L (no) 1986-02-03 1987-02-02 Antihistaminpreparater inneholdende n-heterocyklyl-4-piperidinaminer.

Country Status (26)

Country Link
EP (1) EP0232937B1 (no)
JP (2) JPH0794393B2 (no)
CN (1) CN1018614B (no)
AT (1) ATE79620T1 (no)
AU (1) AU583706B2 (no)
CA (1) CA1327579C (no)
CY (1) CY1865A (no)
DE (1) DE3781173T2 (no)
DK (1) DK173674B1 (no)
EG (1) EG17993A (no)
ES (1) ES2052544T3 (no)
FI (1) FI870448A7 (no)
GR (1) GR3006158T3 (no)
HK (1) HK114695A (no)
HU (1) HU201067B (no)
IE (1) IE60885B1 (no)
IL (1) IL81448A (no)
MA (1) MA20868A1 (no)
NO (1) NO870407L (no)
NZ (1) NZ219165A (no)
PH (1) PH24738A (no)
PT (1) PT84234B (no)
TN (1) TNSN87015A1 (no)
ZA (1) ZA87744B (no)
ZM (1) ZM1287A1 (no)
ZW (1) ZW2087A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
US4897401A (en) * 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
US4988689A (en) * 1987-07-01 1991-01-29 Janssen Pharmaceutica N.V. ((Pharmacologically active bicyclic heterocyclic)methyl and -heteroatom) substituted hexahydro-1H-azepines and pyrrolidines
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives
IT1229231B (it) * 1989-05-08 1991-07-26 Dompe Farmaceutici Spa Aminoimidazopiridine farmacologicamente attive
CA2043564A1 (en) * 1990-07-06 1992-01-07 Alfons G. M. De Knaep 3-[(5-methyl-2-furanyl)methyl]-n-(4-piperidinyl)-3h-imidazo [4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments
CA2143610C (en) * 1992-09-03 2004-08-24 Raymond L. Woosley Use of norastemizole for the treatment of allergic disorders
AU730229B2 (en) * 1992-09-03 2001-03-01 Sepracor, Inc. Use of norastemizole for the treatment of allergic disorders
FI955523A7 (fi) * 1993-05-20 1995-11-16 Kissei Pharmaceutical 1-(2-bentsimidatsolyyli)-1,5-diatsasyklo-oksataaniyhdisteet
TW429256B (en) * 1995-12-27 2001-04-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
WO1998042379A2 (en) * 1997-03-26 1998-10-01 Sepracor Inc. Chemically and thermally stable norastemizole formulations
US5817823A (en) * 1997-04-17 1998-10-06 Sepracor Inc. Method for synthesizing 2-substituted imidazoles
CZ20014573A3 (cs) 1999-06-28 2002-05-15 Janssen Pharmaceutica N. V. Inhibitory replikace respiračně syncyciálního viru
ES2215683T3 (es) 1999-06-28 2004-10-16 Janssen Pharmaceutica N.V. Inhibidores de la replicacion del virus sincitial respiratorio.
CZ20014574A3 (cs) 1999-06-28 2002-05-15 Janssen Pharmaceutica N. V. Inhibitory replikace respiračně syncyciálního viru
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
WO2004113297A2 (en) * 2003-06-24 2004-12-29 Neurosearch A/S Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1706403B9 (en) 2003-12-22 2012-07-25 K.U.Leuven Research & Development Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
ATE426601T1 (de) 2004-12-21 2009-04-15 Gilead Sciences Inc Imidazoa4,5-cupyridinverbindung und verfahren zur antiviralen behandlung
JP5065908B2 (ja) * 2004-12-24 2012-11-07 プロシディオン・リミテッド Gタンパク質結合受容体作動薬
ATE478075T1 (de) 2005-03-08 2010-09-15 Janssen Pharmaceutica Nv Diazaspiro-ä4,4ü-nonanderivate als neurokinin- (nk1)-antagonisten
ATE454384T1 (de) 2006-07-07 2010-01-15 Gilead Sciences Inc Neue pyridazinverbindung und ihre verwendung
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
AU2009296820B2 (en) * 2008-09-26 2014-03-20 Merck Sharp & Dohme Llc Novel cyclic benzimidazole derivatives useful anti-diabetic agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140119A (en) * 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4219559A (en) 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
IN156065B (no) * 1982-07-12 1985-05-04 Janssen Pharmaceutica Nv
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
EP0144101B1 (en) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4588722A (en) * 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
PL144514B1 (en) * 1984-01-09 1988-06-30 Janssen Pharmaceutica Nv Method of obtaining novel derivatives of n-/4-piperidinolo/-2-imidazoloamine

Also Published As

Publication number Publication date
EG17993A (en) 1991-08-30
CA1327579C (en) 1994-03-08
FI870448A7 (fi) 1987-08-04
EP0232937A3 (en) 1988-04-06
JPH0819126B2 (ja) 1996-02-28
AU583706B2 (en) 1989-05-04
ZM1287A1 (en) 1988-08-29
PH24738A (en) 1990-10-01
CY1865A (en) 1996-04-05
JPS62215575A (ja) 1987-09-22
HK114695A (en) 1995-07-21
MA20868A1 (fr) 1987-10-01
DK173674B1 (da) 2001-06-05
GR3006158T3 (no) 1993-06-21
TNSN87015A1 (fr) 1990-01-01
PT84234B (pt) 1989-09-14
ATE79620T1 (de) 1992-09-15
CN87100563A (zh) 1987-08-19
IE60885B1 (en) 1994-08-24
FI870448A0 (fi) 1987-02-02
EP0232937A2 (en) 1987-08-19
JPH07179458A (ja) 1995-07-18
IL81448A (en) 1990-09-17
DE3781173D1 (de) 1992-09-24
IE870258L (en) 1987-08-03
AU6821887A (en) 1987-08-06
NZ219165A (en) 1990-04-26
IL81448A0 (en) 1987-09-16
ZA87744B (en) 1988-10-26
NO870407D0 (no) 1987-02-02
ZW2087A1 (en) 1988-08-31
EP0232937B1 (en) 1992-08-19
HUT44544A (en) 1988-03-28
ES2052544T3 (es) 1994-07-16
CN1018614B (zh) 1992-10-14
JPH0794393B2 (ja) 1995-10-11
PT84234A (en) 1987-03-01
HU201067B (en) 1990-09-28
DK54187A (da) 1987-08-04
DK54187D0 (da) 1987-02-02
DE3781173T2 (de) 1992-12-17

Similar Documents

Publication Publication Date Title
NO870407L (no) Antihistaminpreparater inneholdende n-heterocyklyl-4-piperidinaminer.
RU94019971A (ru) Производные 1,3-дигидро-2н-имидазо /4,5-в/хинолин-2-она в качестве ингибиторов, фосфодиэстеразы, способ их получения, промежуточные для них, фармацевтическая композиция и способ ее получения
DE60123277D1 (de) Makrolidantibiotika
NO975901L (no) Vinyl-pyrrolidinon cefalosporiner med basiske substituenter
SE0002476D0 (sv) New compounds
NO912414D0 (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
ES2007377A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica
FI872930A0 (fi) Analogiamenetelmä ripulinvastaisten 4-(bentsoyyliamino)piperidiinibutaaniamidijohdannaisten valmistamiseksi
UY26459A1 (es) 3,4-dihidroquinazolinas 5,6-disustituidas
RU2003104017A (ru) Ингибиторы тромбина, содержащие аминоизохинолиновую группу
RU2021128535A (ru) Синергетическая композиция, содержащая четвертичное аммониевое соединение и карнозиновую кислоту для применения в качестве антибактериального, антигрибкового средства
RU2024120685A (ru) Инъекционная фармацевтическая композиция для лечения респираторных заболеваний у животных
JP2023075371A (ja) 新型コロナウイルス感染症(covid-19)の予防または治療剤および医薬組成物
DE69103068D1 (de) Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält.
ATE30592T1 (de) Penicillinderivate.
KR890001561A (ko) 세균감염 치료용 약제학적 제제